Growth Response and Differentiation of Bone Marrow-Derived Mesenchymal Stem/Stromal Cells in the Presence of Novel Multiple Myeloma Drug Melflufen

Mesenchymal stem/stromal cells (MSCs) are self-renewing and multipotent progenitors, which constitute the main cellular compartment of the bone marrow stroma. Because MSCs have an important role in the pathogenesis of multiple myeloma, it is essential to know if novel drugs target MSCs. Melflufen is...

詳細記述

書誌詳細

主要な著者:	Arjen Gebraad, Roope Ohlsbom, Juho J. Miettinen, Promise Emeh, Toni-Karri Pakarinen, Mikko Manninen, Antti Eskelinen, Kirsi Kuismanen, Ana Slipicevic, Fredrik Lehmann, Nina N. Nupponen, Caroline A. Heckman, Susanna Miettinen
フォーマット:	Artigo
言語:	Inglês
出版事項:	MDPI AG 2022-05-01
シリーズ:	Cells
主題:	melflufen melphalan flufenamide peptide–drug conjugate mesenchymal stem/stromal cells multiple myeloma bone marrow
オンライン･アクセス:	https://www.mdpi.com/2073-4409/11/9/1574
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!